HOME Sitemap Contact Us
R&D
Introduction
PIatform technology
Pipeline
Research Alliance
R&DPlatform technology

PENTAMBODY™


Penta amino acid mutated bispecific antibody



A NEXT generation bispecific antibody


platform technology.





  • • Natural IgG-like properties: stability, affinity, immunogenicity and PK
  • • Good manufacturability with high yield and purity (no mispairing)
  • • Diverse applications with minimal engineering
  • • Clinical evaluation of the platform on-going
  • WHAT WE ARE
  • WHAT WE DO
  • WHAT WE HAVE
Penta AA mutated bispecific antibody at CH3 domain

Copyright ⓒ 2010 Beijing Hanmi Pharmaceutical Co., LTD. All rights reserved.

Email : admin@bjhanmi.com.cn 咨询电话:800-810-1156 400-650-5676(周一至周五9:00-17:00)

京ICP备05069016号 互联网药品信息服务资格证书 (京)-非经营性-2017-0103 京公网安备11011302001197